Direct Extubation Versus Extubation After a Spontaneous Breathing Trial in Patients at Low Risk of Extubation Failure
Condition(s) studied
Investigational drug(s) / intervention(s)
Weaning strategy with direct extubation (no spontaneous breathing trial): Patients will be extubated within the 60 minutes following randomization
Weaning strategy with extubation only after a successful spontaneous breathing: Patients will undergo a spontaneous breathing trial and will be extubated only in case of successful spontaneous breathing
Study summary
This randomized controlled open label trial aims at comparing a weaning strategy including a spontaneous breathing trial as a prerequisite for extubation to a weaning strategy without a spontaneous breathing trial (direct extubation) in patients with readiness to be weaned criteria and considered at low risk of extubation failure. The main endpoint will be the proportion of patients successfully extubated within the 24 hours after randomization as compared to extubation after a successful spontaneous breathing trial (SBT).
Eligibility
Primary outcome measure(s)
- Proportion of patients extubated within the 24 hours after randomization and who will remain free from mechanical ventilation until 72 hours. — From Day 1 to Day 3
The rate of patients extubated within the 24 hours after randomization and who will remain free from mechanical ventilation until 72 hours.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Pitié Salpêtrière | Paris | France | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07019636 on ClinicalTrials.gov ↗ ← All trials in France